Common Contracts
2 similar Master Collaboration Agreement contracts by ArcherDX, Inc.
MASTER COLLABORATION AGREEMENTMaster Collaboration Agreement • June 5th, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • New York
This Master Collaboration Agreement (this “Agreement”) is made effective as of December 6, 2017 (the “Effective Date”), by and between Archer DX, Inc. a Delaware corporation with offices at 2477 55th Street, Suite 202, Boulder, CO 80301 USA (“ARCHER”), and Merck KGaA, a corporation with general partners under German law, with offices at Frankfurter Strasse 250, 64293 Darmstadt, Germany (including its Affiliates, “MRK”). MRK and ARCHER are each sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”.
MASTER COLLABORATION AGREEMENTMaster Collaboration Agreement • May 22nd, 2020 • ArcherDX, Inc. • In vitro & in vivo diagnostic substances • New York
This Master Collaboration Agreement (this “Agreement”) is made effective as of December 6, 2017 (the “Effective Date”), by and between Archer DX, Inc. a Delaware corporation with offices at 2477 55th Street, Suite 202, Boulder, CO 80301 USA (“ARCHER”), and Merck KGaA, a corporation with general partners under German law, with offices at Frankfurter Strasse 250, 64293 Darmstadt, Germany (including its Affiliates, “MRK”). MRK and ARCHER are each sometimes hereinafter referred to individually as a “Party” and collectively as the “Parties”.
